Fuller & Thaler Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111M | Sell |
|
|||||
|
2025
Q1 | $151M | Sell |
|
|||||
|
2024
Q4 | $188M | Sell |
|
|||||
|
2024
Q3 | $204M | Sell |
|
|||||
|
2024
Q2 | $183M | Buy |
|
|||||
|
2024
Q1 | $132M | Buy |
|
|||||
|
2023
Q4 | $94.8M | Buy |
|
|||||
|
2023
Q3 | $97.3M | Sell |
|
|||||
|
2023
Q2 | $95.5M | Sell |
|
|||||
|
2023
Q1 | $117M | Sell |
|
|||||
|
2022
Q4 | $147M | Sell |
|
|||||
|
2022
Q3 | $115M | Sell |
|
|||||
|
2022
Q2 | $154M | Sell |
|
|||||
|
2022
Q1 | $119M | Sell |
|
|||||
|
2021
Q4 | $158M | Buy |
|
|||||
|
2021
Q3 | $130M | Buy |
|
|||||
|
2021
Q2 | $112M | Buy |
|
|||||
|
2021
Q1 | $101M | Buy |
|
|||||
|
2020
Q4 | $13.8M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $10K | Hold |
|
|||||
|
2019
Q1 | $15K | Hold |
|
|||||
|
2018
Q4 | $14K | Hold |
|
|||||
|
2018
Q3 | $16K | Buy |
|
|||||
|
2018
Q2 | $14K | Hold |
|
|||||
|
2018
Q1 | $14K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $3.93M | Buy |
|
|||||
|
2015
Q4 | $4.64M | Buy |
|
|||||
|
2015
Q3 | $144K | Buy |
|
|||||
|
2015
Q2 | $174K | Sell |
|
|||||
|
2015
Q1 | $207K | Buy |
|
|||||
|
2014
Q4 | $129K | Buy |
|
|||||
|
2014
Q3 | $90K | Sell |
|
|||||
|
2014
Q2 | $80K | Sell |
|
|||||
|
2014
Q1 | $141K | Buy |
|
|||||
|
2013
Q4 | $102K | Hold |
|
|||||
|
2013
Q3 | $71K | Buy |
|